MedTrace Logo

Find HDV and Determine Its Status in Turkey

NCT06248580 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-08-12

No results posted yet for this study

Summary

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.

Conditions

Interventions

DIAGNOSTIC_TEST

Anti Delta

Anti Delta by ELISA

Sponsors & Collaborators

  • SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY

    collaborator UNKNOWN

  • Gilead Sciences

    collaborator INDUSTRY

  • Yaşar Bayındır, MD

    lead OTHER

Principal Investigators

  • Mustafa Kemal Çelen, MD · Dicle University, Medical Faculty, Department of Infectious Diseases

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-11
Primary Completion
2025-02-01
Completion
2025-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06248580 on ClinicalTrials.gov